Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-23T22:24:41.081Z Has data issue: false hasContentIssue false
  • English
  • Français

The Relationship of Plasma to Erythrocyte Lithium Levels in Patients Taking Lithium Carbonate

Published online by Cambridge University Press:  29 January 2018

C. R. Lee ,
S. E. Hill ,
M. Dimitrakoudi ,
F. A. Jenner  and
R. J. Pollitt
C. R. Lee
Affiliation:
Medical Research Council Unit for Metabolic Studies in Psychiatry, University Department of Psychiatry, Middlewood Hospital, P.O. Box 134, Sheffield, S6 1TP
S. E. Hill
Affiliation:
Medical Research Council Unit for Metabolic Studies in Psychiatry, University Department of Psychiatry, Middlewood Hospital, P.O. Box 134, Sheffield, S6 1TP
M. Dimitrakoudi
Affiliation:
Medical Research Council Unit for Metabolic Studies in Psychiatry, University Department of Psychiatry, Middlewood Hospital, P.O. Box 134, Sheffield, S6 1TP
F. A. Jenner
Affiliation:
Medical Research Council Unit for Metabolic Studies in Psychiatry, University Department of Psychiatry, Middlewood Hospital, P.O. Box 134, Sheffield, S6 1TP
R. J. Pollitt
Affiliation:
Medical Research Council Unit for Metabolic Studies in Psychiatry, University Department of Psychiatry, Middlewood Hospital, P.O. Box 134, Sheffield, S6 1TP
Get access Rights & Permissions [Opens in a new window]

Summary

Plasma and erythrocyte lithium levels have been determined repeatedly in twelve patients taking lithium carbonate for affective disorders. In any individual the plot of the plasma lithium level against erythrocyte/plasma ratio is linear, but the ratio can either increase or decrease with increasing plasma lithium concentration. Erythrocyte/plasma ratio is an unsound basis for comparing individual responses to lithium.

Type
Papers
Information
The British Journal of Psychiatry , Volume 127 , Issue 6 , December 1975 , pp. 596 - 598
Copyright
Copyright © Royal College of Psychiatrists, 1975 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Elizur, A., Shopsin, B., Gershon, S. & Ehlenberger, A. (1972) Clinical Pharmacology & Therapeutics, 13, 947.CrossRefGoogle Scholar
Frazer, A., Secunda, S. K. & Mendels, J. (1972) Clinica Chimica Acta, 36, 499.CrossRefGoogle Scholar
Greil, W., Schnelle, K. & Seibold, S. (1974) Arzneimittel-Forschung, 24, 1079.Google Scholar
Gurney, C., Roth, M. & Garside, R. F. (1970) Proceedings of the Royal Society of Medicine, 63, 232.CrossRefGoogle Scholar
Lyttkens, L., Söderberg, U. & Wetterberg, L. (1973) The Lancet, i, 40.CrossRefGoogle Scholar
Mendels, J. & Frazer, A. (1973) Journal of Psychiatric Research, 10, 9.CrossRefGoogle Scholar
Rybakowski, J., Chlopocka, M., Kapelski, Z., Hernacka, B., Szajnerman, Z. & Kasprzak, K. (1974) International Pharmacopsychiatry, 9, 166.CrossRefGoogle Scholar
Soucek, K., Zvolsky, P., Krulik, R., Filip, V., Vinarova, E. & Dostal, T. (1974) Activitas Nervosa Superior (Praha), 16, 193.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.